Neuberger Berman Group LLC Sarepta Therapeutics, Inc. Transaction History

Neuberger Berman Group LLC

$118 Billion
Q2 2024

A detailed history of Neuberger Berman Group LLC transactions in Sarepta Therapeutics, Inc. stock. As of the latest transaction made, Neuberger Berman Group LLC holds 88,451 shares of SRPT stock, worth $11 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

88,451

Previous 85,661 3.26%

Holding current value

$11 Million

Previous $11.1 Million 26.03%

% of portfolio

0.01%

Previous 0.01%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	BUY	$113.33 - $163.85 $316,190 - $457,141	2,790 Added 3.26%	88,451 $14 Million
Q1 2024 May 13, 2024	BUY	$93.7 - $141.53 $8.03 Million - $12.1 Million	85,661 New	85,661 $11.1 Million
Q4 2023 Feb 09, 2024	SELL	$67.31 - $124.76 $72,694 - $134,740	-1,080 Reduced 1.52%	70,141 $6.76 Million
Q3 2023 Nov 14, 2023	SELL	$102.5 - $123.59 $2,870 - $3,460	-28 Reduced 0.04%	71,221 $8.63 Million
Q2 2023 Aug 11, 2023	BUY	$106.4 - $157.19 $2,340 - $3,458	22 Added 0.03%	71,249 $8.16 Million
Q1 2023 May 12, 2023	BUY	$117.53 - $155.99 $7.87 Million - $10.4 Million	66,988 Added 1580.28%	71,227 $9.82 Million
Q4 2022 Feb 13, 2023	SELL	$100.86 - $132.13 $1,109 - $1,453	-11 Reduced 0.26%	4,239 $549,000
Q3 2022 Nov 15, 2022	BUY	$75.71 - $119.24 $7,949 - $12,520	105 Added 2.53%	4,250 $470,000
Q2 2022 Aug 15, 2022	BUY	$62.69 - $88.44 $81,810 - $115,414	1,305 Added 45.95%	4,145 $311,000
Q1 2022 May 13, 2022	BUY	$63.15 - $90.42 $179,346 - $256,792	2,840 New	2,840 $222,000
Q1 2021 May 13, 2021	SELL	$72.25 - $168.95 $2.73 Million - $6.38 Million	-37,779 Closed	0 $0
Q4 2020 Feb 10, 2021	BUY	$125.56 - $178.74 $4.74 Million - $6.75 Million	37,779 New	37,779 $6.42 Million
Q3 2019 Nov 13, 2019	SELL	$72.81 - $156.91 $4.48 Million - $9.65 Million	-61,500 Closed	0 $0
Q2 2019 Aug 13, 2019	BUY	$112.21 - $151.95 $168,315 - $227,924	1,500 Added 2.5%	61,500 $9.35 Million
Q1 2019 May 13, 2019	SELL	$106.67 - $151.68 $218,993 - $311,399	-2,053 Reduced 3.31%	60,000 $7.15 Million
Q4 2018 Feb 12, 2019	SELL	$97.32 - $148.76 $6.76 Million - $10.3 Million	-69,500 Reduced 52.83%	62,053 $6.77 Million
Q3 2018 Nov 13, 2018	SELL	$115.31 - $161.51 $76,911 - $107,727	-667 Reduced 0.5%	131,553 $21.2 Million
Q2 2018 Aug 13, 2018	BUY	$71.74 - $153.69 $7.68 Million - $16.5 Million	107,042 Added 425.14%	132,220 $17.5 Million
Q1 2018 May 08, 2018	BUY	$54.02 - $82.27 $399,910 - $609,044	7,403 Added 41.65%	25,178 $1.87 Million
Q4 2017 Feb 14, 2018	SELL	$47.64 - $56.75 $344,199 - $410,018	-7,225 Reduced 28.9%	17,775 $989,000
Q3 2017 Nov 15, 2017	BUY	$35.73 - $47.15 $893,249 - $1.18 Million	25,000	25,000 $1.13 Million

Others Institutions Holding SRPT

# of Institutions

561

Shares Held

85.5M

Call Options Held

3.67M

Put Options Held

1.75M

View Full List

About Sarepta Therapeutics, Inc.

Ticker SRPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 87,567,904
Market Cap $10.9B
Description
Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection to treat duchenne muscular dystrophy (duchenne) in patients with confirmed mut...

More about SRPT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Neuberger Berman Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Neuberger Berman Group LLC with notifications on news.

Account

Neuberger Berman Group LLC Sarepta Therapeutics, Inc. Transaction History